The Problem

Canada has a proud history of innovation in life sciences, but we’re falling behind. Drug approval systems are slow. Investment is shrinking. Clinical trials are declining. And we’re spending limited resources restructuring medical coverage instead of strengthening innovation and access.

The Problem

Canada has a proud history of innovation in life sciences, but we’re falling behind. Drug approval systems are slow. Investment is shrinking. Clinical trials are declining. And we’re spending limited resources restructuring medical coverage instead of strengthening innovation and access.

By signing up, you agree to receive periodic emails from Medicine Matters Canada containing news, updates, and ways to get involved. Medicine Matters Canada is an initiative of Innovative Medicines Canada (“IMC”). These emails may be sent on IMC’s behalf by our service provider. You can unsubscribe at any time. Contact: Innovative Medicines Canada | 310-99 rue Bank St. Ottawa, ON K1P 6B9 | info@imc-mnc.ca